
Opinion|Videos|December 22, 2025
The Role of Treatment Center Coordinators for CAR T-Cell Therapy Administration in Myeloma
Maximilian Merz, MD, and Carrie Bellerive, BS, RN, BMTCN, explain the role of treatment center coordinators in CAR T-cell therapy administration in multiple myeloma.
Advertisement
Episodes in this series

Maximilian Merz, MD, and Carrie Bellerive, BS, RN, BMTCN, explain the critical role of treatment center coordinators in the delivery of CAR T-cell therapy for patients with multiple myeloma. They outline responsibilities spanning patient education, scheduling, coordination of leukapheresis, and post-infusion monitoring. Merz and Bellerive highlight how effective coordination helps optimize safety, efficiency, and patient experience throughout the CAR T-cell process.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5





































